Home NECC Pharmaceutical Case

NECC Pharmaceutical Case

Identification of Victims in Investigation of the New England Compounding Center

Between approximately May and September, 2012, the New England Compounding Center (NECC) distributed three lots of preservative-free methylprednisolone acetate (MPA) to approximately 76 out-patient surgery centers in 20 different states. The Centers for Disease Control and Prevention (CDC), in collaboration with state and local health departments and the Food and Drug Administration (FDA), continues to investigate and monitor a multistate outbreak of fungal meningitis and other infections among patients who received contaminated preservative-free MPA steroid injections from these three lots.

The FBI, the FDA’s Office of Criminal Investigations, and other federal agencies opened a criminal investigation of NECC in October 2012. The FBI is concerned about the devastating impact the outbreak has had on victims and their families. Providing information and assistance to victims is an important part of our work. If you or a family member were a victim of the fungal meningitis outbreak, we request you submit the information identified below. For more information, see http://www.fbi.gov/stats-services/victim_assistance/seeking-victim-information/identifying-victims-in-the-investigation-of-new-england-compounding-center.

Please complete this questionnaire if you or a family member: (All must apply)

1. Received an injection of preservative-free methylprednisolone acetate (MPA);
2. In a dosage of 80 mg/ml;
3. Between May 1, 2012 and October 15, 2012
4. At one of these facilities Facilities

If you do not meet the criteria listed above, but believe that another medication distributed by NECC caused harm to you or a family member, please complete all the information specified as required below and answer questions 9 and 10. Items marked with a red square are required. See our Victim Assistance page for more details.

I received the injection personally:  


I am completing this form for a family member who received the injection:  


If you are completing this form for a family member, please indicate if your family member has passed away.


Please complete the following four boxes ONLY if you are completing this form for a family member:
Your family member's information:
ALL users complete the following:
YOUR name and Date of Birth
Check If:  



Check If:



Relevant Medical Information
4. When did you or your family member receive the injection(s) during the relevant time period between May and October 2012?
First injection
/ /  
Second injection (if applicable)
/ /  
Third injection (if applicable)
/ /  
Fourth injection (if applicable)
/ /  
5. Have you or your family member received treatment for any condition or symptom resulting from your use of MPA from NECC?



6. If yes to the question 5, have you or your family member been treated with an anti-fungal medication such as Voriconazole, Amphotericin B, AmBisome, Posconazole, or Itraconazole?



7. If yes to the question 6, have you or your family member been treated with a surgical or medical procedure such as laminectomy, removal of infected tissue, drainage of a sac or abscess?



8. Have you or your family member been admitted to a hospital for any condition or symptom resulting from your use of MPA from NECC?



9. Do you believe that another medication distributed by NECC caused harm to you or a family member?



 

Thank you for completing this questionnaire. Please keep copies of all of your medical records.